Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogeneic bone marrow‐derived mesenchymal stromal cells (MSC) o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cells Transl Med
Main Authors: Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Cell‐based Drug Development, Screening, and Toxicology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519760/
https://ncbi.nlm.nih.gov/pubmed/32573983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0099
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares